Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
The prototype cysteinyl leukotriene receptor antagonist, montelukast, is generally considered to have a niche application in the therapy of exercise- and aspirin-induced asthma. It is also used as add-on therapy in patients whose asthma is poorly controlled with inhaled corticosteroid monotherapy, o...
Saved in:
Main Authors: | Gregory R. Tintinger, Charles Feldman, Annette J. Theron, Ronald Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2010.229 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
by: A. J. Theron, et al.
Published: (2014-01-01) -
Roles of 5-Lipoxygenase and Cysteinyl-Leukotriene Type 1 Receptors in the Hematological Response to Allergen Challenge and Its Prevention by Diethylcarbamazine in a Murine Model of Asthma
by: Daniela Masid-de-Brito, et al.
Published: (2014-01-01) -
Cytokine-Leukotriene Receptor Interactions
by: Marek Rola-Pleszczynski, et al.
Published: (2007-01-01) -
The Role of Leukotriene Receptor Signaling in Inflammation and Cancer
by: Ramin Massoumi, et al.
Published: (2007-01-01) -
Sleeptalking! Sleepwalking! Side Effects of Montelukast
by: Samer Alkhuja, et al.
Published: (2013-01-01)